Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Gastroenterology

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2012.07.097PMID 22841784PMCID PMC3756935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non‐1 HCV genotypes

  2012cited by this paper
• Role of Hepatitis C virus genotype 3 in liver fibrosis progression – a systematic review and meta‐analysis

  2011cited by this paper
• Impact of patatin‐like phospholipase‐3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

  2011cited by this paper
• Blood pressure loci identified with a gene-centric array.

  2011cited by this paper
• IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study

  2011cited by this paper
• Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma

  2011cited by this paper
• Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.

  2011cited by this paper
• Patatin‐Like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

  2011cited by this paper
• Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers

  2011cited by this paper
• Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets

  2011cited by this paper
• Apoptosis as a mechanism for liver disease progression.

  2010cited by this paper
• MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

  2010cited by this paper
• Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

  2010cited by this paper
• Interferon γ receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection

  2010cited by this paper
• Hepatitis C Virus Inhibits DNA Damage Repair through Reactive Oxygen and Nitrogen Species and by Interfering with the ATM-NBS1/Mre11/Rad50 DNA Repair Pathway in Monocytes and Hepatocytes

  2010cited by this paper
• LocusZoom: regional visualization of genome-wide association scan results

  2010cited by this paper
• Tubby and tubby‐like protein 1 are new MerTK ligands for phagocytosis

  2010cited by this paper
• Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

  2010cited by this paper
• Genome-wide association study of hematological and biochemical traits in a Japanese population

  2010cited by this paper
• Variant in PNPLA3 is associated with alcoholic liver disease

  2010cited by this paper
• IL28B and the control of hepatitis C virus infection.

  2010cited by this paper
• Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

  2009influential reference
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

  2009cited by this paper
• Human genetics of infectious diseases: between proof of principle and paradigm.

  2009cited by this paper
• IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

  2009cited by this paper
• Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

  2009cited by this paper
• Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.

  2008cited by this paper
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

  2008cited by this paper
• Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.

  2008influential reference
• TAM receptors are pleiotropic inhibitors of the innate immune response.

  2007cited by this paper
• A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C

  2007influential reference
• PLINK: a tool set for whole-genome association and population-based linkage analyses.

  2007cited by this paper
• Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS).

  2007cited by this paper
• GeneTrail—advanced gene set enrichment analysis

  2007cited by this paper
• Genomics of liver fibrosis and cirrhosis.

  2007cited by this paper
• Principal components analysis corrects for stratification in genome-wide association studies

  2006cited by this paper
• Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

  2006cited by this paper
• Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C

  2006cited by this paper
• Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies

  2006cited by this paper
• A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.

  2004cited by this paper
• Improving the accuracy of long‐term prognostic estimates in hepatitis C virus infection

  2004cited by this paper
• Apoptosis: The nexus of liver injury and fibrosis

  2004cited by this paper
• A gene atlas of the mouse and human protein-encoding transcriptomes.

  2004cited by this paper
• NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

  2003cited by this paper
• Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal.

  2003cited by this paper
• Human sensitive to apoptosis gene protein inhibits peroxynitrite-induced DNA damage.

  2003cited by this paper
• Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal

  2003cited by this paper
• Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic

  2003cited by this paper
• Phagocytosis and clearance of apoptotic cells is mediated by MER

  2001cited by this paper
• Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa

  2000cited by this paper
• SAG, a Novel Zinc RING Finger Protein That Protects Cells from Apoptosis Induced by Redox Agents

  1999cited by this paper
• Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

  1999cited by this paper
• TULP1 mutation in two extended Dominican kindreds with autosomal recessive Retinitis pigmentosa

  1998cited by this paper
• Recessive mutations in the gene encoding the tubby-like protein TULP1 in patients with Retinitis pigmentosa

  1998cited by this paper
• Hepatitis C

  1998cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• An algorithm for the grading of activity in chronic hepatitis C

  1996cited by this paper
• Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C

  1994cited by this paper
• Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

  1994cited by this paper
• Practical Nonparametric Statistics

  1972cited by this paper

• The OAS-RNase L pathway: Insights from experiments of nature.

  2026cites this paper
• Genetic modulators of metabolic dysfunction-associated steatotic liver disease (MASLD) and their epistatic interactions: from in vitro and animal models to clinical outcomes.

  2026cites this paper
• Genome-wide association and gene-virus interaction study of liver disease in hepatitis C virus-infected patients

  2025cites this paper
• A feeding-induced myokine modulates glucose homeostasis

  2025cites this paper
• GAS6/TAM Axis as Therapeutic Target in Liver Diseases

  2024cites this paper
• Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease

  2024cites this paper
• Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression

  2024cites this paper
• MERTK and Fibrosis: A New Target for Therapy

  2024cites this paper
• MERTK in the rat trigeminal system: a potential novel target for cluster headache?

  2024cites this paper
• The diverse roles of macrophages in metabolic inflammation and its resolution

  2023cites this paper
• Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis

  2023cites this paper
• Genetic Factors for the Natural Elimination of Hepatitis C Virus

  2023cites this paper
• The Multifaceted Roles of Macrophages in NAFLD Pathogenesis

  2023cites this paper
• Evaluation of the epidemiological significance of molecular genetic factors in relation to the intensity of post-vaccination immunity against hepatitis B

  2022cites this paper
• Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

  2022cites this paper
• The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review

  2022cites this paper
• Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development

  2022cites this paper
• Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication

  2022cites this paper
• Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators

  2022cites this paper
• Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians.

  2021cites this paper
• Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors

  2021influential citation
• Genetic susceptibility to congenital Zika syndrome: Current research and future perspectives

  2021cites this paper
• A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure

  2021cites this paper
• Human inborn errors of immunity to oncogenic viruses.

  2021cites this paper
• Natural History of Hepatitis C Infection

  2021cites this paper
• A Systematic Review of Animal Models of NAFLD Finds High‐Fat, High‐Fructose Diets Most Closely Resemble Human NAFLD

  2021cites this paper
• MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective

  2021cites this paper
• A genome-wide association study for nonalcoholic fatty liver disease identifies novel genetic loci and trait-relevant candidate genes in the Million Veteran Program.

  2021cites this paper
• Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?

  2020cites this paper
• A systematic analysis of rodent models implicates adipogenesis and innate immunity in pathogenesis of fatty liver disease

  2020cites this paper
• MerTK, a risk factor for NASH fibrosis

  2020cites this paper
• The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice

  2020cites this paper
• Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer

  2020cites this paper
• Macrophages in metabolic associated fatty liver disease

  2020cites this paper
• Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway

  2020cites this paper
• Direct acting antivirals therapy and hepatocellular carcinoma risk in patients with hepatitis C virus

  2020cites this paper
• Differential TAM receptor regulation of hepatic physiology and injury

  2020cites this paper
• Genes and NAFLD/NASH Progression

  2020cites this paper
• Human genetics of HCV infection phenotypes in the era of direct-acting antivirals

  2020cites this paper
• Viral Escape Mechanisms in Hepatitis C and the Clinical Consequences of Persistent Infection

  2020cites this paper
• Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy.

  2019cites this paper
• Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression.

  2019cites this paper
• Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update

  2019cites this paper
• Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?

  2019cites this paper
• An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank

  2019cites this paper
• Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease

  2019cites this paper
• Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients

  2019cites this paper
• Genetic loss of Gas6/Mer pathway attenuates silica-induced lung inflammation and fibrosis in mice.

  2019cites this paper
• The features of immunogenetic profile and biochemical indicators in patients with chronic hepatitis B

  2019cites this paper
• Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients

  2019cites this paper
• Interferon lambda 4 impacts the genetic diversity of hepatitis C virus

  2019cites this paper
• Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis

  2019cites this paper
• Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis

  2019cites this paper
• Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology

  2019cites this paper
• University of Dundee Interferon lambda 4 impacts the genetic diversity of hepatitis C virus

  2019influential citation
• GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

  2019cites this paper
• Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing

  2019cites this paper
• Exploring the interactions between the human and viral genomes

  2019cites this paper
• Genetic variants that associate with cirrhosis have pleiotropic effects on human traits

  2019cites this paper
• Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.

  2019cites this paper
• Genetics of Infectious Diseases

  2019cites this paper
• The Association of Single Nucleotide Polymorphisms with Cancer Risk

  2019cites this paper
• Genome-Wide Association Studies

  2019cites this paper
• Embryonic or Induced Pluripotent Stem Cell-Derived Hepatocellular Systems for HCV Culture.

  2018cites this paper
• HCV-Associated Liver Fibrosis and HSD17B13.

  2018cites this paper
• Elina Virtanen

  2018cites this paper
• Host genetic variations associated with disease progression in chronic hepatitis C virus infection

  2018cites this paper
• The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study

  2018influential citation
• [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

  2018cites this paper
• [Prophylaxis, diagnosis and therapy of hepatitis-C-virus (HCV) infection: the German guidelines on the management of HCV infection - AWMF-Register-No.: 021/012].

  2018influential citation
• Interferon lambda 4 impacts broadly on hepatitis C virus diversity

  2018cites this paper
• Hepatitis C: Host and Viral Factors Associated with Response to Therapy and Progression of Liver Fibrosis

  2018cites this paper
• Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes

  2018cites this paper
• S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus (HCV) -Infektion“

  2018cites this paper
• Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals

  2018cites this paper
• TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy

  2018cites this paper
• Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.

  2017cites this paper
• Genome-to-genome analysis highlights the impact of the human innate and adaptive immune systems on the hepatitis C virus

  2017cites this paper
• Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study

  2017cites this paper
• Viral and host factors associated with outcomes of hepatitis C virus infection (Review).

  2017cites this paper
• Triplex High-Resolution Melting Assay for the Simultaneous Assessment of IFNL3 rs12979860, ABCB11 rs2287622, and RNF7 rs16851720 Genotypes in Chronic Hepatitis C Patients.

  2017cites this paper
• PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.

  2017cites this paper
• A TWO-STAGE GENOME-WIDE ASSOCIATION STUDY CONFIRMS PNPLA 3 AND IDENTIFIES TM 6 SF 2 AND MBOAT 7 AS RISK LOCI FOR ALCOHOL-RELATED CIRRHOSIS

  2017cites this paper
• Protective effects of ellagic acid against tetrachloride-induced cirrhosis in mice through the inhibition of reactive oxygen species formation and angiogenesis

  2017cites this paper
• Genome-Wide Association Study Identi fi es TLL 1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection

  2017cites this paper
• Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making

  2017cites this paper
• Прогнозирование скорости развития фиброза печени у больных хроническим гепатитом с на основе комбинации генетических и средовых факторов

  2017cites this paper
• Association between genetic polymorphisms of the IL28B gene and leukomonocyte in Chinese hepatitis B virus-infected individuals

  2017influential citation
• ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients

  2017cites this paper
• Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.

  2017cites this paper
• Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.

  2017cites this paper
• TM6SF2 rs58542926 Polymorphism is not Associated With Risk of Steatosis or Fibrosis in Chilean Patients With Chronic Hepatitis C

  2017cites this paper
• Serum markers of apoptosis and inflammation in patients with chronic hepatitis C virus

  2017cites this paper
• Chapter 17 – Viral Hepatitis

  2017cites this paper
• Mechanisms of accelerated liver fibrosis in HIV-HCV coinfection.

  2017cites this paper
• MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat

  2017cites this paper
• Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches

  2017cites this paper
• Genome-to-genome analysis highlights the impact of the human innate and adaptive immune systems on the hepatitis C virus

  2017cites this paper
• Identification of novel variants in HLA class II region related to HLA DPB1 expression and disease progression in patients with chronic hepatitis C

  2017cites this paper
• A new 3 p 25 locus is associated with liver fibrosis progression in HIV / HCV co-infected patients

  2016cites this paper